UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 27, 2022

Accession Number:	0001193125-22-081609
Submission Type:	POS AM
CIK: 0001796280 Company Name: Oric Pharmaceuticals, Inc. File Number: 333-255833